Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-003159

Options or other derivatives

  • Chief Medical Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HUMPHREY RACHEL · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-01-25 Grant or award : show line 1 in the form Stock Option (right to buy) +120,000 120,000 D
Loading xslF345X03/doc1.xml…